These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9455985)

  • 1. Characterization of Campylobacter jejuni isolates from patients with Guillain-Barré syndrome.
    Nishimura M; Nukina M; Kuroki S; Obayashi H; Ohta M; Ma JJ; Saida T; Uchiyama T
    J Neurol Sci; 1997 Dec; 153(1):91-9. PubMed ID: 9455985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Campylobacter jejuni isolates from Japanese patients with Guillain-Barré syndrome.
    Saida T; Kuroki S; Hao Q; Nishimura M; Nukina M; Obayashi H
    J Infect Dis; 1997 Dec; 176 Suppl 2():S129-34. PubMed ID: 9396696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome (GBS).
    Gregson NA; Rees JH; Hughes RA
    J Neuroimmunol; 1997 Mar; 73(1-2):28-36. PubMed ID: 9058756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PCR-based restriction fragment length polymorphism (RFLP) analysis and serotyping of Campylobacter jejuni isolates from diarrheic patients in China and Japan.
    Nishimura M; Nukina M; Yuan JM; Shen BQ; Ma JJ; Ohta M; Saida T; Uchiyama T
    FEMS Microbiol Lett; 1996 Sep; 142(2-3):133-8. PubMed ID: 8810495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barré syndrome exhibit mimicry of GM1 ganglioside.
    Prendergast MM; Lastovica AJ; Moran AP
    Infect Immun; 1998 Aug; 66(8):3649-55. PubMed ID: 9673245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes.
    Endtz HP; Ang CW; van Den Braak N; Duim B; Rigter A; Price LJ; Woodward DL; Rodgers FG; Johnson WM; Wagenaar JA; Jacobs BC; Verbrugh HA; van Belkum A
    J Clin Microbiol; 2000 Jun; 38(6):2297-301. PubMed ID: 10834992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restriction fragment length polymorphism analysis and random amplified polymorphic DNA analysis of Campylobacter jejuni strains isolated from patients with Guillain-Barré syndrome.
    Fujimoto S; Allos BM; Misawa N; Patton CM; Blaser MJ
    J Infect Dis; 1997 Oct; 176(4):1105-8. PubMed ID: 9333178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections.
    Hao Q; Saida T; Kuroki S; Nishimura M; Nukina M; Obayashi H; Saida K
    J Neuroimmunol; 1998 Jan; 81(1-2):116-26. PubMed ID: 9521613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome.
    Jacobs BC; Endtz HP; van der Meché FG; Hazenberg MP; de Klerk MA; van Doorn PA
    J Neuroimmunol; 1997 Oct; 79(1):62-8. PubMed ID: 9357448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationship between Guillain-Barre syndrome and serotypes of Campylobacter jejuni isolated from the patients].
    Li H; Yuan J; Shen B; Sun X; Hao H
    Zhonghua Nei Ke Za Zhi; 1999 Jul; 38(7):455-7. PubMed ID: 11798680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative genotyping of Campylobacter jejuni strains from patients with Guillain-Barré syndrome in Bangladesh.
    Islam Z; van Belkum A; Wagenaar JA; Cody AJ; de Boer AG; Tabor H; Jacobs BC; Talukder KA; Endtz HP
    PLoS One; 2009 Sep; 4(9):e7257. PubMed ID: 19789649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains.
    Lastovica AJ; Goddard EA; Argent AC
    J Infect Dis; 1997 Dec; 176 Suppl 2():S139-43. PubMed ID: 9396698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
    Yuki N
    J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between pathogenesis of Guillain-Barre syndrome and Penner's serotypes of Campylobacter jejuni.
    Li H; Yuan J; Shen B; Sun X; Hao H
    Chin Med J (Engl); 1999 Sep; 112(9):794-6. PubMed ID: 11717947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study between an outbreak of Guillain-Barre syndrome in Jilin, China, and preceding Campylobacter jejuni infection.
    Zhang M; Li Q; He L; Meng F; Gu Y; Zheng M; Gong Y; Wang P; Ruan F; Zhou L; Wu J; Chen L; Fitzgerald C; Zhang J
    Foodborne Pathog Dis; 2010 Aug; 7(8):913-9. PubMed ID: 20455754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome.
    Jacobs BC; Hazenberg MP; van Doorn PA; Endtz HP; van der Meché FG
    J Infect Dis; 1997 Mar; 175(3):729-33. PubMed ID: 9041356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of DNA sequence variation in Campylobacter jejuni strains associated with the Guillain-Barré syndrome by high-throughput AFLP analysis.
    Godschalk PC; Bergman MP; Gorkink RF; Simons G; van den Braak N; Lastovica AJ; Endtz HP; Verbrugh HA; van Belkum A
    BMC Microbiol; 2006 Apr; 6():32. PubMed ID: 16594990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome.
    Yuki N; Ichihashi Y; Taki T
    J Neuroimmunol; 1995 Jul; 60(1-2):161-4. PubMed ID: 7543907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
    Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
    J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies.
    Kimoto K; Koga M; Odaka M; Hirata K; Takahashi M; Li J; Gilbert M; Yuki N
    Neurology; 2006 Nov; 67(10):1837-43. PubMed ID: 17130419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.